HOPE VALLEY AI

About HOPE VALLEY AI

HOPE Valley AI develops a smartphone-based e-Clinic that utilizes Trustworthy Risk-Informed Artificial Intelligence to predict breast cancer risk and detect early signs of abnormalities. This technology addresses the challenge of late-stage breast cancer diagnoses by empowering patients to monitor their breast health and enabling healthcare providers to identify potential issues before they escalate.

```xml <problem> Late-stage diagnosis of breast cancer remains a significant challenge, leading to decreased survival rates. Current methods often rely on infrequent mammograms, potentially missing interval cancers that develop between screenings. Many women are unaware of their individual risk factors and lack tools for proactive breast health monitoring. </problem> <solution> HOPE Valley AI offers a smartphone-based digital clinic that uses AI to predict breast cancer risk and facilitate early detection. The platform empowers patients to conduct regular breast health self-checks under the supervision of their healthcare provider. By integrating risk-informed AI, the application aims to identify subtle indicators of potential abnormalities, enabling timely intervention and improved outcomes. The technology assists in "knowing my normal" by tracking changes and reporting any unusual symptoms or weak signals to the user and their physician. </solution> <features> - AI-powered risk prediction based on individual health data and risk factors - Guided breast self-examination with abnormality detection and reporting - Monitoring of breast skin changes, lumps, nipple discharge, and other symptoms - Secure data storage and transmission to healthcare providers - Personalized breast health education and awareness resources </features> <target_audience> The primary target audience includes women seeking proactive breast health management and healthcare providers looking for tools to improve early detection and risk assessment. </target_audience> ```

What does HOPE VALLEY AI do?

HOPE Valley AI develops a smartphone-based e-Clinic that utilizes Trustworthy Risk-Informed Artificial Intelligence to predict breast cancer risk and detect early signs of abnormalities. This technology addresses the challenge of late-stage breast cancer diagnoses by empowering patients to monitor their breast health and enabling healthcare providers to identify potential issues before they escalate.

Where is HOPE VALLEY AI located?

HOPE VALLEY AI is based in La Rochelle, France.

When was HOPE VALLEY AI founded?

HOPE VALLEY AI was founded in 2024.

Who founded HOPE VALLEY AI?

HOPE VALLEY AI was founded by Hakima BERDOUZ.

  • Hakima BERDOUZ - Founder/CEO
Location
La Rochelle, France
Founded
2024
Employees
1 employees
Looking for specific startups?
Try our free semantic startup search

HOPE VALLEY AI

Score: 53/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

HOPE Valley AI develops a smartphone-based e-Clinic that utilizes Trustworthy Risk-Informed Artificial Intelligence to predict breast cancer risk and detect early signs of abnormalities. This technology addresses the challenge of late-stage breast cancer diagnoses by empowering patients to monitor their breast health and enabling healthcare providers to identify potential issues before they escalate.

hopevalleyai.com700+
Founded 2024 – La Rochelle, France

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (<5)

Hakima BERDOUZ

Founder/CEO

Company Description

Problem

Late-stage diagnosis of breast cancer remains a significant challenge, leading to decreased survival rates. Current methods often rely on infrequent mammograms, potentially missing interval cancers that develop between screenings. Many women are unaware of their individual risk factors and lack tools for proactive breast health monitoring.

Solution

HOPE Valley AI offers a smartphone-based digital clinic that uses AI to predict breast cancer risk and facilitate early detection. The platform empowers patients to conduct regular breast health self-checks under the supervision of their healthcare provider. By integrating risk-informed AI, the application aims to identify subtle indicators of potential abnormalities, enabling timely intervention and improved outcomes. The technology assists in "knowing my normal" by tracking changes and reporting any unusual symptoms or weak signals to the user and their physician.

Features

AI-powered risk prediction based on individual health data and risk factors

Guided breast self-examination with abnormality detection and reporting

Monitoring of breast skin changes, lumps, nipple discharge, and other symptoms

Secure data storage and transmission to healthcare providers

Personalized breast health education and awareness resources

Target Audience

The primary target audience includes women seeking proactive breast health management and healthcare providers looking for tools to improve early detection and risk assessment.